Who is BlueRock?
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
What Are We Doing?
Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.
We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.
We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.
BlueRock is seeking a talented and highly motivated full-time co-op intern to join the Cell Banking Process Development function/sub-team within the Process Development (PD) team. The candidate will contribute to the process of generation of high-quality cell banks of human pluripotent stem cells (hPSCs) that form the foundation of cell-based therapies. The primary responsibilities will be supporting process development for cell banking and upstream manufacturing towards the goal of ultimately tech transferring process changes and improvements from R&D to GMP. There will also be the opportunity to collaborate with other groups within the Process Development team as well as internal and external development partners. In the bigger picture, the successful candidate will be part of developing novel cell-based therapies and bringing regenerative medicines to those who are suffering with intractable diseases. Our dynamic workplace is attractive to those who are self-motivated and resourceful.